Friedman-Urevich S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate.

Farley S, Gottesman MH, Friedman-Urevich S, Ye J, Shen M, Grueneberg D, Martone L, Calixte R. Farley S, et al. Among authors: friedman urevich s. Surg Neurol Int. 2019 Apr 24;10:59. doi: 10.25259/SNI-4-2019. eCollection 2019. Surg Neurol Int. 2019. PMID: 31528397 Free PMC article.

Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS).

Gottesman MH, Friedman-Urevich S. Gottesman MH, et al. Among authors: friedman urevich s. Mult Scler. 2006 Jun;12(3):271-80. doi: 10.1191/135248506ms1261oa. Mult Scler. 2006. PMID: 16764339 Clinical Trial.

Neutralizing antibodies to 500 microg interferon beta-1b: 28-month results of the IDEAS extension trial.

Gottesman MH, Friedman-Urevich S, Boylan E, Cheng D. Gottesman MH, et al. Among authors: friedman urevich s. Mult Scler. 2010 Jan;16(1):78-80. doi: 10.1177/1352458509352665. Epub 2009 Dec 7. Mult Scler. 2010. PMID: 19995836

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis: 2-year follow-up (investigational new drug No. 65863).

Gladstone DE, Peyster R, Baron E, Friedman-Urevich S, Sibony P, Melville P, Gottesman M. Gladstone DE, et al. Among authors: friedman urevich s. Am J Ther. 2011 Jan;18(1):23-30. doi: 10.1097/MJT.0b013e3181b3ad95. Am J Ther. 2011. PMID: 19770795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters